drugset / Trial / NCT07503002
Shortened LSD Intervention for Major Depressive Disorder
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2027-07-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lysergic Acid Diethylamide | Other / unclassified | 250 ug | Oral |
| Subject | Risperidone | Other / unclassified | 1 mg | Oral |